Latest week
10 Jul 2026
Close
2.000000
Fair value
1.873344
Next-week expectancy
Negative 41.92%
Sharemaestro

TXMD Chart Pack

TherapeuticsMD Inc

Exchange
NASDAQ
Latest week
10 Jul 2026
Close
2.000000
Fair value
1.873344
Next-week expectancy
Negative 41.92%
Generated
15 Jul 2026 23:15
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, TXMD fell 8.68%, moving from 2.19 to 2.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 7 of the last 12 weeks. Relative Strength is -1.91 and has softened across the 12-week window. Market Dynamics is -0.41 on the latest week. Next-week expectancy is negative at 41.92% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
2.00
12-Week Change
-8.68%
Trend Signal
Inactive
Next-Week Expectancy
Negative 41.92%
Signal Weeks
7 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-1.91
Market Dynamics
-0.41

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
2.00
12-Week Change
-8.68%
Trend Signal
Inactive
Next-Week Expectancy
Negative 41.92%
Signal Weeks
7 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-1.91
Market Dynamics
-0.41

Over the latest 12 completed weeks ending 2026-07-10, TXMD fell 8.68%, moving from 2.19 to 2.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 7 of the last 12 weeks. Relative Strength is -1.91 and has softened across the 12-week window. Market Dynamics is -0.41 on the latest week. Next-week expectancy is negative at 41.92% based on similar historical setup states.

Industry Peers

United States equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
TLPH Talphera Inc. NASDAQ 10 Jul 2026 1.06 1.50 1.00 1.46 37.74%
AKBA Akebia Ther NASDAQ 10 Jul 2026 1.25 1.46 1.23 1.40 12.45%
ZYBT Zhengye Biotechnology Holding Limited Ordinary Shares NASDAQ 10 Jul 2026 0.69 0.82 0.63 0.78 12.43%
BCRX BioCryst Pharmaceuticals Inc NASDAQ 10 Jul 2026 9.80 11.22 9.71 10.45 6.63%
BFRI Biofrontera Inc NASDAQ 10 Jul 2026 1.04 1.21 1.03 1.10 5.77%
INM InMed Pharmaceuticals Inc NASDAQ 10 Jul 2026 1.56 1.70 1.56 1.64 5.13%
AYTU Aytu BioScience Inc NASDAQ 10 Jul 2026 2.16 2.30 2.15 2.25 4.17%
SNOA Sonoma Pharmaceuticals Inc NASDAQ 10 Jul 2026 1.21 1.31 1.19 1.26 4.13%
RMTI Rockwell Medical Inc NASDAQ 10 Jul 2026 5.43 6.14 5.39 5.61 3.31%
IRWD Ironwood Pharmaceuticals Inc NASDAQ 10 Jul 2026 4.33 4.88 4.27 4.47 3.23%
CABR Caring Brands, Inc. Common Stock NASDAQ 10 Jul 2026 1.30 1.52 1.30 1.34 3.08%
INDV Indivior PLC Ordinary Shares NASDAQ 10 Jul 2026 39.41 41.60 39.20 40.50 2.77%
ANIK Anika Therapeutics Inc NASDAQ 10 Jul 2026 15.30 16.49 14.93 15.60 1.96%
SUPN Supernus Pharmaceuticals Inc NASDAQ 10 Jul 2026 47.62 51.37 46.76 48.46 1.76%
XERS Xeris Pharmaceuticals Inc NASDAQ 10 Jul 2026 8.20 9.02 8.20 8.34 1.71%
CTOR Citius Oncology, Inc. NASDAQ 10 Jul 2026 0.68 0.74 0.67 0.69 1.47%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Earnings vs Price

This view compares the weekly close with rolling TTM EPS. Both lines are indexed to 100 at the first visible week, so the chart shows whether price is moving faster or slower than earnings across the full chart window.

If rolling EPS rises faster than price, the gap is positive and the implied multiple has compressed. If price rises faster than rolling EPS, the gap is negative and the move is more dependent on multiple expansion.

Quarterly EPS points are shown as updates to the rolling earnings line. Use this alongside Trend Line, Fair Value, Market Dynamics, and Smart Money context.